Only a minority consistently meet timely targets set out by the AHA and ACC. This is a “call to action,” Harold Dauerman says ...

Using the PREVENT risk equation, one-fifth were at high risk over 10 years, rising to two-thirds over the next 30 years.

Alcohol is a hot topic—the new statement sums up the evidence and provides ways to help patients understand the risks.

Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.

The imaging was better than societal recommendations at discriminating long-term risk of ventricular arrhythmias.

Lp(a) only modestly improved prediction when added to risk estimates, but it still can be used to personalize care.

The advent of ATTR-specific drugs, though pricey, is enabling better survival in these overlapping diseases, researchers say.

Karmpaliotis leaves behind a legacy of teaching his profound skills in complex PCI and his passion for patients and family.

With the factor XI inhibitor, clinicians may have more flexibility when managing anticoagulation in this common scenario.

The GLUCOSE (Glucose Level Understanding and Control Optimized for Safety and Efficacy) model is based on 6,148 ICU patients ...

Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

The aim is to “activate these guidelines in a way that they become more actionable for clinicians,” Harlan Krumholz says.